300 80
Ansor

Portfolio News: Kaleidex announces major new Yorkshire manufacturing facility to strengthen UK medtech capability

Home » News & Insights » Portfolio News: Kaleidex announces major new Yorkshire manufacturing facility to strengthen UK medtech capability

Kaleidex One will strengthen UK medtech manufacturing capability with advanced automation, cleanroom capacity, and end-to-end production solutions.

Kaleidex group has announced plans for Kaleidex One: a major new purpose-built precision manufacturing facility in Yorkshire designed to expand the UK’s advanced medical manufacturing capabilities and support the next generation of medical device innovation.

Set to open in 2027, the 60,000 sq ft Factory of the Future will become a centre of excellence for the rapidly growing contract manufacturing organisation (CMO), bringing together advanced precision engineering, implant manufacturing, cleanroom assembly, rapid prototyping, automation, and product development under one roof.

The investment represents a significant commitment to advanced manufacturing in the North of England and reinforces the region’s growing role as a hub for high-value medical technology and engineering expertise.

Kaleidex One is being designed to support both global OEMs and emerging medical technology businesses by offering fully integrated end-to-end manufacturing solutions from concept development and prototyping through to scale-up production, finishing, sterile packing, and inspection.

The facility will introduce levels of automation rarely seen within UK medical manufacturing and is expected to strengthen the UK’s position as a globally competitive location for medtech innovation and production.

Gavin Meadows, CEO of Kaleidex group, said:

“Kaleidex One represents a major step forward not only for our business, but for the wider UK medical technology sector.

We are investing in a world-class advanced manufacturing environment that brings together cutting-edge technology, specialist expertise, and scalable production capability to help our customers accelerate innovation and bring life-enhancing products to market faster.

Yorkshire has a proud manufacturing heritage, and we believe the North of England has a critical role to play in the future of global medtech manufacturing.”

The new site will include dedicated rapid prototyping and new product introduction (NPI) cells, expanded cleanroom capacity for sterile assembly and packing, advanced finishing capabilities, automated clean lines, and enhanced quality assurance facilities.

Kaleidex One will also house the Kaleidex Academy and an Advanced Development Team skunkworks space focused on training, experimentation, and process innovation; helping develop the next generation of engineering and manufacturing talent in the region.

The company says the facility has been specifically designed to support increasing demand for implant manufacturing and scalable production for both established OEMs and high-growth medtech innovators.

The announcement comes amid growing focus on strengthening UK supply chains, expanding regional manufacturing investment, and supporting high-value industries through innovation-led growth.

Further details on Kaleidex One will be shared throughout 2026 ahead of the facility opening in 2027.

 

About Kaleidex

Kaleidex is a leading Contract Manufacturing Organisation (CMO) specialising in the design, development, and production of precision-engineered medical devices. With a strong commitment to innovation and collaboration, Kaleidex, backed by private equity firm Ansor, acquires and integrates high-performing medical manufacturing companies, building a network of expertise and innovation to drive industry advancements.

Related articles

How can we help?

Get in Touch

Get in Touch

Please get in touch using the form below.

Close form

Professional Investor Disclaimer

DISCLAIMER

General Notice

RELIANCE ON THIS WEBSITE AND INFORMATION (THE “WEBSITE”) FOR THE PURPOSE OF ENGAGING IN ANY INVESTMENT ACTIVITY MAY EXPOSE AN INDIVIDUAL TO A SIGNIFICANT RISK OF LOSING ALL CAPITAL INVESTED. PLEASE NOTE THAT FOR REGULATORY PURPOSES, BY PROCEEDING WE WILL BE TREATING YOU AS A PROFESSIONAL INVESTOR IN ACCORDANCE WITH THE CLIENT CATEGORISATION RULES AS PRESCRIBED IN THE FCA HANDBOOK.

If you are in any doubt about the action you should take or the contents of this website you should contact your professional advisers authorised under the Financial Services and Markets Act 2000.

This legal and regulatory notice is issued by Ansor LLP. Ansor LLP is authorised and regulated by the Financial Conduct Authority, with Firm Reference Number 1018078. If you do not accept the terms of this disclaimer do not continue to use or access any pages of this Website. Ansor LLP is registered as a limited liability partnership in England and Wales, with registered number OC427505 and its registered office at 50 Hans Road, London SW1X 0NA.

 Legal Disclaimer

Ansor LLP provides the Website for the purpose of general information purposes only and the information and materials contained therein should not be relied upon as a substitute for financial or other professional advice. Nothing on this Website constitutes: (i) an offer, advice, invitation or solicitation by Ansor LLP or its affiliates to buy or sell any investments or securities, futures, options or other financial instruments; (ii) an invitation or inducement to engage in investment activity or a financial promotion of any kind; or (iii) investment advice or recommendation. Ansor LLP makes no representation or warranties of any kind with respect to the Website or the information and materials contained therein and disclaims all such representations and warranties including, without limitation, representations or warranties about the accuracy, completeness, or suitability for any purpose of the information and materials published in the Website. Further information may be available on request. Ansor LLP may make changes to the material on the Website at any time without notice and is under no obligation to update the Website nor to notify users of any changes to the Website at any time. Ansor LLP has no obligation to notify a reader or recipient of this publication in the event that any matter, opinion, projection, forecast or estimate contained herein, changes or subsequently becomes inaccurate. Neither Ansor LLP nor any of its directors, employees or other representatives will be liable for loss or damage arising out of or in connection with the use of this Website. This limitation of liability applies to all damages of any kind, including without limitation: compensatory; direct; indirect or consequential damages; loss of data; loss of income or profit; loss of or damages to property; and claims of third parties.

Any reference to “We” within the Website is defined as Ansor LLP acting as investment adviser to Ansor Fund I LP and Ansor IB LP. Investment management services to Ansor Fund I LP and Ansor IB LP are provided by Ansor LLP.

Regulatory Notice and Risks

Please read the information set out below. Potential investors should consult their financial adviser before making any investments. Potential investors should also fully consider the available information, including, but not limited to the risk warnings set out below.Investing entails risks, including possible loss of principal. No representation is being made that any investment or transaction will or is likely to achieve profits or losses similar to those achieved in the past, or that significant losses will be avoided. No assurances or guarantees are given regarding the performance of any investment.

Past performance may not be repeated and should not be seen as a guide to future performance.

The value of investments and the income from them may go down as well as up and investors may not get back the amount originally invested. Any estimates of future performance are based on assumptions that may not be realised. Some investments may have a high level of volatility. High volatility investments may experience sudden and large falls in their value which may cause losses. International investing includes risks related to political and economic uncertainties of foreign countries, as well as currency risk. To the extent permitted by applicable law, no liability whatsoever is accepted for any direct or consequential loss, damages, costs or prejudices whatsoever arising from the use of this Website. This Website or any information supplied in connection with this Website by any person is or not to be taken as constituting the giving of investment advice or connection with your proposed investment.
Cookies

A “cookie” is a piece of information that is saved to your PC’s hard disk by the web server. Confirmation of reading and accepting this disclaimer will place a cookie on your PC’s hard disk. This will ease your navigation around this Website by not popping up this disclaimer again during this browser session. This cookie is temporary and will be removed when you close your browser. The cookie is not used for any other reason.

Telephone Recording

Ansor LLP may monitor and record telephone conversations to check and verify instructions, to maintain high quality service standards, to comply with regulatory requirements and for the security of operational and business processes.

Marketing

The distribution of the information on this Website may be restricted by law in certain countries. This Website and the information on it is not addressed to any person resident in the territory or country or jurisdiction where such distribution would be contrary to local law or regulation. Ansor LLP disclaims all responsibility if you access or download any information from this Website in breach of any law or regulation in the country of which you are a citizen or in which you are residing or domiciled.

Conditions of Use

If you have read and understood these conditions of use you may click the “I AGREE” button to proceed. By doing so you acknowledge that you understand the conditions of use and have agreed to abide by them.

By clicking “I AGREE” below this will certify that you have read the above disclaimer and that you understand and agree that:

  • Nothing contained on this Website is deemed to be an offer to buy or sell an investment;
  • You are a professional investor;
  • The value of investments can go down as well as up and there is the possibility of losing all of your investment.
  • Some or all investment services or products may not be available to you in your jurisdiction.